047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Treatment
F.D. Richard Hobbs, FMedSci
Head of Primary Care
University of Oxford
Oxford, England, United Kingdom
Hugh Montgomery, MD
University College London
London, England, United Kingdom
Francisco Padilla, MD
Centro de Investigación en Cardiología y Metabolismo
Guadalajara, Jalisco, Mexico
Jesus Abraham Simón Campos, MD
DIRECTOR
Köhler & Milstein Research/Hospital Agustín O’Horán
Mérida, Yucatan, Mexico
Douglas Arbetter, MPH
AstraZeneca
Waltham, Massachusetts, United States
Seth Seegobin, PhD
AstraZeneca
Cambridge, England, United Kingdom
Alexandre Kiazand, MD
AstraZeneca
Gaithersburg, Maryland, United States
Katie Streicher, PhD (she/her/hers)
Head of Translational Medicine, Vaccines and Immune Therapies
AstraZeneca
Gaithersburg, Maryland, United States
Nuria Martinez-Alier, PhD
AstraZeneca
Cambridge, England, United Kingdom
Taylor Cohen, PhD
Global Project Lead
AstraZeneca
Gaithersburg, Maryland, United States
Mark T. Esser, PhD
Phylogenetic and alpha toxin variant analyses of Staphylococcus aureus strains isolated from patient
AstraZeneca
Gaithersburg, Maryland, United States